Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells - Wikidata - awgldk - TriplyDB

Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells

Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells

http://www.wikidata.org/entity/Q34068899

about

Emerging targets in lipid-based therapy Ceramide mediates FasL-induced caspase 8 activation in colon carcinoma cells to enhance FasL-induced cytotoxicity by tumor-specific cytotoxic T lymphocytes Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II.Metformin Induces Cell Cycle Arrest and Apoptosis in Drug-Resistant Leukemia Cells.

P2860

Q28655456-35992BA6-4E0F-453E-BCB2-44145C5263AB Q30357159-68EB96CC-EA62-442F-8D31-3CE4CA8056E2 Q41828412-60102409-06FB-45F5-91A6-6B56226BAB67 Q42093002-4C469D5B-622F-440F-94F0-1F52FE6D4FF4

P2860

Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells

http://www.wikidata.org/entity/Q34068899

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells

@ast

Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells

@en

Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells

@nl

type

label

Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells

@ast

Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells

@en

Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells

@nl

prefLabel

Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells

@ast

Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells

@en

Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells

@nl

P1433

Q34068899-52F876EF-7D56-41B1-BD7A-3ED9ADBFC0F6

P1476

Q34068899-9C25B896-7B9F-4478-BCCF-E6C00AFE5024

P2093

Q34068899-2BE43FC8-1EA9-4F66-AB5E-4D8FE6C61F9D

Q34068899-3D7EA1FD-E383-489F-9B4C-25549D5559B4

Q34068899-A9924BC9-77C8-4FEF-897A-71144B6915DE

Q34068899-D9B0819E-A076-4CE6-8963-33AED579DBB2

Q34068899-F582A599-7956-4704-93E9-7EC0B05F8165

P2860

Q34068899-131ACFF4-5B76-4457-9868-DC740AB1D374

Q34068899-151C7E89-DEE6-4E52-A16C-AF0EDC914287

Q34068899-1988674C-2AD8-4354-ADB2-3A0BCE7C2EF1

Q34068899-1B8F7B7A-ECA6-4EAE-9A8E-C41CF9F4C899

Q34068899-236F0061-59E6-4F86-87E4-A0B7E4E7BF1E

Q34068899-26BEB633-ABF4-4C15-BCF7-565B08810B87

Q34068899-2E59A6B4-D217-49BF-89B6-06E3BB2C41D0

Q34068899-3BF25F62-78C3-4AA8-A16D-7554264C5CAF

Q34068899-410272D9-1E40-4937-B3CA-92B7B17073E2

Q34068899-4406CE01-593B-4CFA-9712-812D17681ACA

P2888

Q34068899-1596D6A6-1352-4114-BF64-0675FFF5FF50

P304

Q34068899-A73DD47C-BADB-43F5-973E-B25C67D95155

P31

Q34068899-0C836F14-CF4C-4998-92C5-027587CF42ED

P356

Q34068899-5D612D1B-89C5-41D5-A364-86F1E26DB1C8

P407

Q34068899-41C8DD8E-2CAB-4730-A84B-B04C288C995A

P478

Q34068899-29B8CD6E-56C0-40A8-8D0E-5FC45B792909

P50

Q34068899-EE5C1E8A-C35C-44BC-8461-22C6730D7A2C

P577

Q34068899-92EE4D31-7F8C-42DF-8C85-8D221D438B84

P5875

Q34068899-616D7F6F-D354-474B-AA71-4243DEEA0310

P6179

Q34068899-9D30DE40-9837-4443-8473-DE0D4E641FFC

P698

Q34068899-4BB57613-2472-4A34-A4F4-D41E3EE39C48

P921

Q34068899-770634C4-6C5E-46BF-9EF7-0C4BE5F1369F

P932

Q34068899-5A6531EA-2E4A-4E66-B453-672D294816B5

P356

1471-2407-11-477

P1433

P1476

Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells

@en

P2093

Aintzane Apraiz

http://www.w3.org/2001/XMLSchema#string

Gorka Pérez-Yarza

http://www.w3.org/2001/XMLSchema#string

Jolanta K Idkowiak-Baldys

http://www.w3.org/2001/XMLSchema#string

María Dolores Boyano

http://www.w3.org/2001/XMLSchema#string

Yusuf A Hannun

http://www.w3.org/2001/XMLSchema#string

P2860

Glucosylceramide synthase and its functional interaction with RTN-1C regulate chemotherapeutic-induced apoptosis in neuroepithelioma cells

Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases

Principles of bioactive lipid signalling: lessons from sphingolipids

Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line

Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid

PKCzeta protects against UV-C-induced apoptosis by inhibiting acid sphingomyelinase-dependent ceramide production

Discovery and evaluation of inhibitors of human sphingosine kinase.

Tailoring structure-function and targeting properties of ceramides by site-specific cationization.

Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.

Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl)retinamide in human ovarian cancer cells.

P2888

1471-2407-11-477

P304

477

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-11-477

http://www.w3.org/2001/XMLSchema#string

P407

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Aintzane Asumendi

P577

2011-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51781502

http://www.w3.org/2001/XMLSchema#string

P6179

1011091919

http://www.w3.org/2001/XMLSchema#string

P698

22061047

http://www.w3.org/2001/XMLSchema#string

P921

P932

3218121

http://www.w3.org/2001/XMLSchema#string